Objective: The objective was to document the acceptability of rehabilitation exoskeletons from the perspective of users with spinal cord injury (SCI) and healthcare professionals (HP). Methods: This mixed-methods systematic review considered quantitative, qualitative and mixed methods studies that included adults with SCI using an exoskeleton for gait rehabilitation, as well as HP working within rehabilitation settings with individuals with SCI who used an exoskeleton. A convergent integrated approach per the Joanna Briggs Institute (JBI) was used. Results: A total of 22 studies were included. Overall, individuals with SCI and HP expressed a favorable level of acceptability. Participants reported a positive affective attitude, an overall satisfaction, and several psychological benefits. Few burdens, ethical issues and opportunity costs have also been reported in the studies. Maintaining realistic expectations towards exoskeleton use and ensuring the appropriate selection of users is important for intervention coherence. In general, there was a positive perception regarding effectiveness and self-efficacy. Nevertheless, only a limited number of studies focused primarily on measuring acceptability, revealing an important gap in the literature. Conclusions: The acceptability of exoskeletons among people with SCI and HP tends to be positive, which is promising for the sustainable implementation of this technology. However, there is still a lack of knowledge about the acceptability of HP, with only two study conducted among this population. It is crucial to persevere in documenting the acceptability of exoskeletons, notably by standardizing comprehensive approaches for measuring acceptability, and to continue refining this technology.

The authors have declared no competing interest.

This work received funding from the Praxis Spinal Cord Institute (Research Grant No: G2020-33) and the Social Sciences and Humanities Research Council (Research Grant No: 892-2021-2033).

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present work are contained in the manuscript